Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2014
09/30/2014US8846083 Method for the diffusion of molecules which are insoluble in an aqueous medium and composition using said method
09/30/2014US8846081 Liposome compositions and methods of use thereof
09/30/2014US8846074 Sublingual films
09/30/2014US8846073 Low temperature processes for making cyclic lipid implants for intraocular use
09/30/2014US8846072 Controlled delivery system
09/30/2014US8846068 Methods and compositions for treating post-operative pain comprising a local anesthetic
09/30/2014US8846066 Methods and related compositions for reduction of fat and skin tightening
09/30/2014US8846065 Ester mixtures and compositions comprising such ester mixtures
09/30/2014US8846061 Multivitamin-mineral regimens for longevity and wellness
09/30/2014US8846050 N-domain of carcinoembryonic antigen and compositions, methods and uses thereof
09/30/2014US8846044 Stabilizing alkylglycoside compositions and methods thereof
09/30/2014US8846039 Method for ameliorating pruritus
09/30/2014US8846030 Compounds and methods to enhance rAAV transduction
09/30/2014US8846029 Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors
09/30/2014US8846028 Mitochondrial enhancement of cells
09/30/2014US8846024 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
09/30/2014US8846023 Hepatitis C virus inhibitors
09/30/2014US8846022 Crosslinked polyalkyleneimine hydrogels with tunable degradation rates
09/30/2014US8846021 Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
09/30/2014US8846019 Use of protoberberines as an active substance regulating the pilosebaceous unit
09/30/2014US8846009 Antimicrobial agents and methods of use
09/30/2014US8846008 Antimicrobial agents and methods of use
09/30/2014US8845612 Methods for iontophoretically treating nausea and migraine
09/30/2014US8845600 Skin care compositions and uses thereof
09/30/2014CA2857543A1 Anti-obesity potential of calebin a
09/30/2014CA2763786C Alkanoylamino benzamide aniline hdac inihibitor compounds
09/30/2014CA2758820C Targeted sustained-release microsphere of vascular occlusive agent containing sodium alginate and sorafenib, production method and use thereof
09/30/2014CA2704279C Method of treating demyelination diseases
09/30/2014CA2684926C Compositions comprising c-13 alkoxyether macrolide compounds and phenylpyrazole compounds
09/30/2014CA2669596C Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
09/30/2014CA2664152C Serine hydrolase inhibitors
09/30/2014CA2661580C Novel salts of the active substance rasagiline
09/30/2014CA2655094C Use of pharmaceutical compositions comprising cannabigerol for the treatment of depression
09/30/2014CA2649361C Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
09/30/2014CA2618871C Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization
09/30/2014CA2610575C Process for the preparation and isolation of phosphatides
09/30/2014CA2586946C Nutrition containing fat blend
09/30/2014CA2576826C 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
09/30/2014CA2576222C Compositions and methods for treating lymphoma
09/30/2014CA2506737C Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll)
09/29/2014CA2847877A1 Prenylflavanone compounds for modulating diabetes
09/25/2014WO2014153559A1 Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine
09/25/2014WO2014153541A1 Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
09/25/2014WO2014153529A1 Substituted benzimidazoles as nociceptin receptor modulators
09/25/2014WO2014153509A1 Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase
09/25/2014WO2014153505A2 Treatment of chemotherapy-induced peripheral neuropathy
09/25/2014WO2014153424A1 Reducing diabetes in patients receiving hmg-coa reductase inhibitors (statins)
09/25/2014WO2014153416A1 Compositions and methods for producing elevated and sustained ketosis
09/25/2014WO2014153415A2 Trail enhancers for the selective killing of cancer cells
09/25/2014WO2014153394A1 Cellular delivery of dna intercalating agents
09/25/2014WO2014153384A1 Corticosteroid formulations for the treatment of joint pain and methods of use thereof
09/25/2014WO2014153356A1 An in vivo intracellular reprogramming composition and method of making and using same
09/25/2014WO2014153337A2 Small molecule inhibitors of pi3-kinase signaling
09/25/2014WO2014153280A1 2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
09/25/2014WO2014153227A1 Methods of preserving and protecting pancreatic beta cells and treating or preventing diabetes by inhibiting nox-1
09/25/2014WO2014153226A1 Arginine methyltransferase inhibitors and uses thereof
09/25/2014WO2014153215A1 Androgen receptor down-regulating agents and uses thereof
09/25/2014WO2014153214A1 Arginine methyl transferase inhibtors and uses thereof
09/25/2014WO2014153208A1 Arginine methyltransferase inhibitors and uses thereof
09/25/2014WO2014153180A1 Methods and compositions for improving cognitive function
09/25/2014WO2014153172A1 Pyrazole derivatives as prmt1 inhibitors and uses thereof
09/25/2014WO2014153150A1 Methods of predicting anti ctla-4 response and recurrence of cancer
09/25/2014WO2014153118A1 Treatment of diseases and conditions associated with dysregulation of mammalian target of rapamycin complex 1 (mtorc1)
09/25/2014WO2014153090A1 Pyrazole derivatives asprmt1 inhibitors and uses thereof
09/25/2014WO2014153055A2 Compounds and methods for treating cancers
09/25/2014WO2014153044A1 Treatment of patients with hyponatremia and cardiac disease
09/25/2014WO2014153043A1 Compounds and methods for treating cancers
09/25/2014WO2014153037A1 Substituted triazolopyridines and methods of use thereof
09/25/2014WO2014153023A1 5-bromo-indirubins
09/25/2014WO2014153009A2 Thiosaccharide mucolytic agents
09/25/2014WO2014153001A1 Combination therapy for treating cancer
09/25/2014WO2014152917A2 Physiological ligands for gpr139
09/25/2014WO2014152869A2 Benzyl urea derivatives for activating tgf-beta signaling
09/25/2014WO2014152864A1 Treatment for chemotherapy-induced cognitive impairment
09/25/2014WO2014152861A2 Methods of treating renal disease and other disorders
09/25/2014WO2014152843A1 Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
09/25/2014WO2014152833A1 3-(substituted-4-oxo-quinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives
09/25/2014WO2014152818A1 Methods of inhibiting cataracts and presbyopia
09/25/2014WO2014152809A2 Analogs of pparo and 20-oh-pge2, and methods of using the same
09/25/2014WO2014152789A1 Citrate containing beverage
09/25/2014WO2014152768A1 Cyclohexanediamine compounds and methods for their preparation
09/25/2014WO2014152754A2 Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
09/25/2014WO2014152738A1 Lxr modulators
09/25/2014WO2014152733A1 A method of providing ocular neuroprotection
09/25/2014WO2014152725A1 S1p and/or atx modulating agents
09/25/2014WO2014152723A1 Ophthalmic formulations
09/25/2014WO2014152716A1 Substituted heterocyclic compounds for treating or preventing viral infections
09/25/2014WO2014152715A1 Use of inhibitors of binding between a par-1 receptor and its ligands for the treatment of glioma
09/25/2014WO2014152663A1 Crystalline forms of tyrosine kinase inhibitors and their salts
09/25/2014WO2014152661A1 Ocular formulations for drug-delivery to the posterior segment of the eye
09/25/2014WO2014152635A1 Combination of direct acting antiviral agents and ribavirin for treating hcv patients
09/25/2014WO2014152621A1 P2x7 modulators
09/25/2014WO2014152606A2 Treatment of insulin resistance associated with prolonged physical inactivity
09/25/2014WO2014152604A1 P2x7 modulators
09/25/2014WO2014152589A1 P2x7 modulators
09/25/2014WO2014152566A2 Methods of synthesizing substituted purine compounds
09/25/2014WO2014152564A1 Methods of acute restoration of vascular compliance
09/25/2014WO2014152562A1 Injectable formulations for treating cancer
09/25/2014WO2014152540A1 Compositions and methods of altering cholesterol levels
09/25/2014WO2014152537A1 P2x7 modulators
1 ... 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 ... 7860